MCGUIRK TERENCE F 4

4 · Atlanta Braves Holdings, Inc. · Filed Dec 8, 2025

Form 4

Period: 2025-12-04

Director

Transactions

Exercise/Conversion
Series C Common Stock
2025-12-04+27,000→ 252,353 total
Sale
Series C Common Stock
2025-12-05$38.63/sh−12,012$464,024→ 240,341 total
Exercise/Conversion
Restricted Stock Units - BATRK
2025-12-04−27,000→ 0 total
From: 2025-12-04Exp: 2025-12-04→ Series C Common Stock (27,000 underlying)
Award
Restricted Stock Units - BATRK
2025-12-04+176,212→ 176,212 total
From: 2026-12-04Exp: 2026-12-04→ Series C Common Stock (176,212 underlying)

Holdings

Footnotes (5)

[F1]Each restricted stock unit converted into one share of Series C Common Stock.
[F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
[F3]Reflects the weighted average sale price. The range of prices for such transaction is $38.29 to $38.77. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
[F4]Reflects shares held in a family trust for which the reporting person's spouse is trustee and the reporting person's children are beneficiaries.
[F5]Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

Documents

1 file